TNF-alpha-induced microglia activation requires miR-342: impact on NF-kB signaling and neurotoxicity

João Paulo Brás1,2,3, Joana Bravo1,3,4, Jaime Freitas1,2

  • 1i3S - Instituto de Investigação e Inovação em Saúde, University of Porto, Rua Alfredo Allen 208, 4200-135, Porto, Portugal.

Insights

Sustained neuroinflammation involves microglia overactivation. This study identifies microRNA-342 (miR-342) as a key mediator in tumor necrosis factor alpha (TNF-α)-induced microglia activation, offering a potential therapeutic target.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Immunology

Background:

  • Sustained neuroinflammation, driven by overactivated microglia, contributes to neurological and psychiatric disorders.
  • Microglia release inflammatory mediators like tumor necrosis factor alpha (TNF-α), creating a self-perpetuating activation cycle.
  • Identifying molecular targets to control TNF-α-mediated microglia overactivation is crucial.

Purpose of the Study:

  • To identify novel microRNAs (miRNAs) regulated by TNF-α in microglia.
  • To elucidate the role of identified miRNAs in microglia activation and neuronal communication.
  • To explore the therapeutic potential of targeting these miRNAs in neuroinflammation.

Main Methods:

  • Primary rat microglia were stimulated with TNF-α.
  • miRNA microarray analysis and RT-qPCR were used to identify differentially expressed miRNAs.
  • Gain- and loss-of-function assays, proteomic analysis, and microfluidic co-cultures with neurons were employed.

Main Results:

  • TNF-α stimulation upregulated miR-342 in microglia.
  • miR-342 overexpression activated the NF-κB pathway, increasing TNF-α and IL-1β secretion.
  • Inhibition of miR-342 reduced cytokine levels and mitigated TNF-α-induced microglia activation.
  • Both TNF-α-stimulated and miR-342-overexpressing microglia impaired neuron viability and increased nitrite levels.

Conclusions:

  • miR-342 is a critical mediator of TNF-α-induced microglia activation.
  • Targeting miR-342 presents a potential strategy to control microglia-driven neuroinflammation.
  • This finding opens new avenues for therapeutic interventions in neurological disorders associated with neuroinflammation.